Vigilare Wealth Management Bei Gene, Ltd. Transaction History

Vigilare Wealth Management

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 19, 2021	SELL	$249.6 - $403.14 $169,728 - $274,135	-680 Closed	0 $0
Q2 2021 Jul 16, 2021	BUY	$292.75 - $367.01 $14,637 - $18,350	50 Added 7.94%	680 $233,000
Q1 2021 Apr 29, 2021	BUY	$260.64 - $382.12 $164,203 - $240,735	630 New	630 $219,000

252

45.3M

292K

119K

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

Get notified when there are updates to the investment portfolio of Vigilare Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Vigilare Wealth Management with notifications on news.